As of 2026-02-14, the Relative Valuation of Amicus Therapeutics Inc (FOLD) is (0.95) USD. This relative valuation is based on P/E multiples. With the latest stock price at 14.31 USD, the upside of Amicus Therapeutics Inc based on Relative Valuation is -106.6%.
The range of the Relative Valuation is (1.02) - (0.87) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.5x - 25.4x | 25.3x |
| Forward P/E multiples | 16.3x - 19.0x | 16.4x |
| Fair Price | (1.02) - (0.87) | (0.95) |
| Upside | -107.2% - -106.1% | -106.6% |
| Date | P/E |
| 2026-02-11 | -313.99 |
| 2026-02-10 | -313.77 |
| 2026-02-09 | -313.77 |
| 2026-02-06 | -313.77 |
| 2026-02-05 | -313.34 |
| 2026-02-04 | -313.12 |
| 2026-02-03 | -313.34 |
| 2026-02-02 | -313.55 |
| 2026-01-30 | -313.55 |
| 2026-01-29 | -313.12 |
| 2026-01-28 | -313.34 |
| 2026-01-27 | -313.55 |
| 2026-01-26 | -313.55 |
| 2026-01-23 | -313.12 |
| 2026-01-22 | -313.12 |
| 2026-01-21 | -314.87 |
| 2026-01-20 | -313.99 |
| 2026-01-16 | -314.43 |
| 2026-01-15 | -313.99 |
| 2026-01-14 | -315.53 |
| 2026-01-13 | -314.21 |
| 2026-01-12 | -313.34 |
| 2026-01-09 | -313.34 |
| 2026-01-08 | -313.34 |
| 2026-01-07 | -313.77 |
| 2026-01-06 | -313.34 |
| 2026-01-05 | -312.68 |
| 2026-01-02 | -313.12 |
| 2025-12-31 | -312.46 |
| 2025-12-30 | -312.68 |
| 2025-12-29 | -312.68 |
| 2025-12-26 | -312.68 |
| 2025-12-24 | -312.68 |
| 2025-12-23 | -311.80 |
| 2025-12-22 | -311.80 |
| 2025-12-19 | -311.14 |
| 2025-12-18 | -238.95 |
| 2025-12-17 | -241.36 |
| 2025-12-16 | -238.95 |
| 2025-12-15 | -238.73 |
| 2025-12-12 | -231.49 |
| 2025-12-11 | -217.23 |
| 2025-12-10 | -216.13 |
| 2025-12-09 | -215.25 |
| 2025-12-08 | -216.13 |
| 2025-12-05 | -217.23 |
| 2025-12-04 | -218.33 |
| 2025-12-03 | -214.60 |
| 2025-12-02 | -213.50 |
| 2025-12-01 | -215.03 |